Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-544-9 | CAS number: 108-03-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
In vitro: One key study and two supporting studies indicated that 1 -nitropropane did not induce reverse mutations in the Salmonella Typhimurium (Ames) test with or without metabolic activation. Similarly, it was negative in a chromosomal aberration test using Chinese hamster lung cells with or without metabolic activation. 1 -Nitropropane was negative in DNA repair tests using rat hepatic or rat, mouse, hamster or human extrahepatic cell lines. Conversely, onein vitrotest indicated that 1-NP enhanced the formation of micronuclei in Chinese Hamster lung cells V79. Another in vitro mammalian cell gene mutation test (HPRT) did show an increase in the number of 6-thioguanine resistant mutations. However, both of these positive results should be interpreted in light of conflicting in vitro testing and the higher tiered in vivo testing, specifically, where the bone marrow micronucleus test and the in vivo rat UDS test were negative.
In vivo: The micronucleus test in the rat did not show an increase in polychromatic erythrocytes in the bone marrow. In the same experiment, liver did have a higher level of micronucleated hepatocytes than control. However, the increase in the frequency of micronuclei in the hepatocyte may be due to increased cell proliferation. Results in the rat confirm earlier findings that 1-nitropropane was negative in the mouse micronucleus test. 1 -Nitropropane did not induce an increase in DNA repair in an in vivo rat UDS study at doses as high as 80 mg/kg. The lack of genotoxic potential is supported by two negative carcinogenicity studies in rats.
Short description of key information:
Eight in vitro studies were identified to evaluate 1-nitropropane for its genotoxicity, these include one key study for the Salmonella typhimurium reverse mutation assay and two supporting studies, a key study for the in vitro mammalian cell chromosomal aberration test, and two in vitro DNA repair tests. Two studies, an in vitro micronucleus assay and an HGPRT are compared with the higher tiered in vivo test to determine the overall classification of 1-ntiropropane. Of the eight studies, three were GLP (DNA repair tests gave no indication that they were or were not GLP) and all were conducted under guideline or comparable to a guideline study.
Three in vivo studies were identified to evaluate 1-nitropropane for its genotoxicity. Two were in vivo rat and mouse micronucleus tests and the other in vivo rat hepatocyte UDS study. All were negative.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Majority of thein vitro and the higher tiered in vivo genotoxicity studies with 1 -nitropropane were negative, therefore no classification for genotoxicity is required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.